Tevogen Bio Holdingsの空売り状況は、投資家がTevogen Bio Holdingsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Tevogen Bio Holdings (NASDAQ:TVGN) 株価情報, 空売り情報

Tevogen Bio Holdings

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Inc

RBC Capital analyst Gregory Renza maintains CG Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) with a Outperform and raises the price target from $66 to $68.

News

Price Target

Analyst Ratings

CGON

RBC Capital Maintains Outperform on CG Oncology, Raises Price Target to $68

Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) shares are rising on Tuesday.
The company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45061121/hilton-reports-first-quarter-results" rel="noreferrer noopener">first-quarter adjusted earnings</a> per share of $1.72, beating the street view of $1.61. Quarterly sales of $2.69 billion missed the analyst <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus estimate of $2.72 billion</a>.
Adjusted EBITDA for the first quarter was $795 million, compared with $750 million a year ago.
Adjusted EBITDA margin expanded to 73.7% from 70.4% in the year-ago period.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44800444/goldman-sachs-cuts-outlook-for-these-hotel-and-lodging-stocks-as-potential-recession-looms" rel="noreferrer noopener">Goldman Sachs Cuts Outlook For These Hotel And Lodging Stocks As Potential Recession Looms</a>
System-wide comparable RevPAR increased 2.5%, on a currency-neutral basis, for the first quarter compared to the same period in 2024.
Quarterly net income margin expanded to 11.1% from 10.4%.
In the first quarter of 2025, the company opened 186 hotels, totaling 20,100 rooms, resulting in 14,000 net room additions.
&#8220;We continued to grow our pipeline of lifestyle properties during the quarter, adding the Tempo by Hilton brand in the U.K., marking the brand&#8217;s first hotel outside of the U.S., the first Tapestry Collection by Hilton and Curio Collection by Hilton hotels in Athens, Greece and Canopy by Hilton in Utah, representing the brand&#8217;s first ski destination,&#8221; the company said.
As of March 31, the firm had $11.2 billion of debt outstanding, excluding the deduction for deferred financing costs and discount.
Total cash and equivalents were $807 million as of March 31, 2025, including $76 million of restricted cash and cash equivalents.
The firm repurchased 3.7 million shares of Hilton common stock during the first quarter, bringing total capital return, including dividends, to $927 million for the quarter and $1,157 million year to date through April.
In April 2025, the company&#8217;s board of directors authorized a regular quarterly cash dividend of $0.15 per share of common stock to be paid on June 27.
Outlook: Hilton Worldwide raised its full-year 2025 adjusted EPS guidance to $7.76–$7.94, up from the previous range of $7.71–$7.82.
The updated full-year outlook compares with the $7.93 analyst estimate.
For the second quarter, Hilton expects adjusted EPS between $1.97 and $2.02, below the $2.11 estimate.
Price Action: HLT shares are trading lower by 1.30% to $224.27 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45065788/general-motors-margins-weaken-amid-tariff-uncertainty-ceo-barra-delays-conference-call-on-guidance-uncertainty" target="_blank" rel="noreferrer noopener">General Motors CEO Delays Earnings Call, Margins Weaken As Tariff Uncertainty Remains</a></li>
</ul>
Photo by josefkubes via Shutterstock

Earnings

Equities

Guidance

Markets

Movers

Trading Ideas

General

Why Is Hilton Worldwide Stock Trading Higher on Tuesday?

Goldman Sachs analyst Duffy Fischer maintains Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) with a Neutral and lowers the price target from $45 to $34.

Goldman Sachs Maintains Neutral on Dow, Lowers Price Target to $34

<a href="https://www.nuvalent.com/">Nuvalent, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>), a clinical-stage biopharmaceutical company focused on creating&nbsp;precisely&nbsp;targeted therapies for clinically proven kinase targets in cancer, today announced the publication of a manuscript in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research,&nbsp;which supports the rational molecular design of zidesamtinib, its novel and selective ROS1 inhibitor. Zidesamtinib is currently being evaluated in the ongoing ARROS-1 Phase 1/2 trial for patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) and other solid tumors, which is designed with registrational intent for tyrosine kinase inhibitor (TKI) pre-treated and TKI-naïve patients with advanced ROS1-positive NSCLC.

NUVL

Nuvalent Publishes Study Supporting Zidesamtinib's Molecular Design in Cancer Treatment

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Underperform and raises the price target from $5 to $5.25.

RBC Capital Maintains Underperform on Cemex, Raises Price Target to $5.25

WIIM

Pfizer shares are trading higher following a Q1 EPS beat. The company reaffirmed guidance but said it is trending towards the upper end of its 2025 Adjusted diluted EPS guidance range.

FFIN

First Financial Increases Its Dividend To $0.19

Novo Nordisk shares are trading higher after the company announced Wegovy partnerships with Hims and LifeMD.

<h3>Gainers</h3>
<ul>
<li>Travelzoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZOO#NASDAQ">TZOO</a>) shares moved upwards by 20.8% to $15.13 during Tuesday's regular session. The market value of their outstanding shares is at $170.1 million. As per the press release, Q1 earnings came out today. </li>
<li>36KR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRKR#NASDAQ">KRKR</a>) stock increased by 16.3% to $5.0. The company's market cap stands at $9.8 million. </li>
<li>LZ Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) stock rose 13.73% to $9.11. The market value of their outstanding shares is at $1.3 billion. </li>
<li>LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) shares rose 13.44% to $0.74. The market value of their outstanding shares is at $71.4 million. </li>
<li>Phoenix New Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) stock rose 11.7% to $2.1. The company's market cap stands at $25.2 million. </li>
<li>EPWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) shares moved upwards by 11.53% to $15.29. The company's market cap stands at $341.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>iOThree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOTR#NASDAQ">IOTR</a>) shares declined by 27.5% to $0.66 during Tuesday's regular session. The company's market cap stands at $16.9 million. </li>
<li>Intelligent Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTJ#NASDAQ">INTJ</a>) shares fell 15.44% to $0.57. The market value of their outstanding shares is at $7.4 million. </li>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) shares declined by 11.01% to $2.91. The market value of their outstanding shares is at $59.3 million. </li>
<li>Beasley Broadcast Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) stock decreased by 10.1% to $5.58. The market value of their outstanding shares is at $9.8 million. </li>
<li>Haoxi Health Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) stock fell 9.63% to $1.31. The market value of their outstanding shares is at $3.6 million. </li>
<li>Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) stock decreased by 9.4% to $2.4. The company's market cap stands at $12.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBGI

EPWK

FENG

INTJ

IOTR

KRKR

LZMH

MSGM

SURG

TZOO

12 Communication Services Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) shares rose 50.4% to $0.02 during Tuesday's regular session. </li>
<li>Kala Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) stock rose 39.13% to $4.97. The market value of their outstanding shares is at $30.2 million. </li>
<li>ENDRA Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) shares increased by 33.48% to $5.74. The market value of their outstanding shares is at $3.0 million. </li>
<li>LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) shares moved upwards by 32.78% to $8.1. The market value of their outstanding shares is at $361.1 million. </li>
<li>iBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#NASDAQ">IBIO</a>) shares increased by 27.14% to $1.33. The market value of their outstanding shares is at $13.1 million. </li>
<li>Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) stock rose 26.12% to $35.92. The company's market cap stands at $8.0 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock decreased by 71.0% to $0.02 during Tuesday's regular session. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) shares decreased by 34.63% to $9.25. The company's market cap stands at $438.3 million. </li>
<li>NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) stock declined by 31.9% to $6.79. The market value of their outstanding shares is at $872.2 million. The company's, Q1 earnings came out today. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock decreased by 25.2% to $4.84. The company's market cap stands at $2.9 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock declined by 23.37% to $4.56. The company's market cap stands at $69.4 million. </li>
<li>Relmada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) stock fell 15.99% to $0.3. The company's market cap stands at $9.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IBIO

KALA

LFMD

LGMK

NDRA

PTPI

RLMD

TIVC

ZYBT

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Clarivate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) shares moved upwards by 16.6% to $4.18 during Tuesday's regular session. The company's market cap stands at $2.8 billion. The company's, Q1 earnings came out today. </li>
<li>Primech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMEC#NASDAQ">PMEC</a>) stock increased by 16.33% to $0.99. The company's market cap stands at $37.7 million. </li>
<li>CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) stock increased by 16.3% to $22.33. The market value of their outstanding shares is at $781.3 million. As per the news, the Q1 earnings report came out today. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares increased by 16.14% to $0.24. The market value of their outstanding shares is at $47.8 million. </li>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) stock moved upwards by 15.15% to $1.52. The market value of their outstanding shares is at $44.3 million. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) stock moved upwards by 14.55% to $1.81. The market value of their outstanding shares is at $24.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marwynn Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MWYN#NASDAQ">MWYN</a>) shares declined by 28.0% to $2.93 during Tuesday's regular session. The company's market cap stands at $49.9 million. </li>
<li>Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) shares declined by 15.81% to $36.0. The company's market cap stands at $687.9 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) stock fell 15.77% to $2.14. The market value of their outstanding shares is at $257.9 million. </li>
<li>Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) shares declined by 15.22% to $66.65. The market value of their outstanding shares is at $2.5 billion. As per the news, the Q1 earnings report came out today. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) shares declined by 15.05% to $0.96. The company's market cap stands at $12.3 million. </li>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock fell 14.78% to $0.36. The market value of their outstanding shares is at $19.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMPX

CECO

CLVT

GTEC

KFRC

LNZA

MWYN

Nuveen Insured California Premium Fund Ii

OMEX

PMEC

UAVS

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) shares increased by 21.8% to $9.1 during Tuesday's regular session. The market value of their outstanding shares is at $15.4 million. As per the press release, FY earnings came out yesterday. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) shares moved upwards by 17.36% to $0.18. The market value of their outstanding shares is at $16.7 million. </li>
<li>Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) stock increased by 14.88% to $25.4. The market value of their outstanding shares is at $336.7 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock moved upwards by 14.17% to $1.36. The market value of their outstanding shares is at $8.3 million. </li>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) stock moved upwards by 13.09% to $5.7. The company's market cap stands at $7.2 million. </li>
<li>Focus Universal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) shares moved upwards by 12.68% to $5.42. The market value of their outstanding shares is at $40.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Daqo New Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares fell 16.1% to $12.42 during Tuesday's regular session. The market value of their outstanding shares is at $816.7 million. The company's, Q1 earnings came out today. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares fell 16.11% to $3.46. The company's market cap stands at $539.0 million. </li>
<li>Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) stock fell 13.61% to $19.27. The market value of their outstanding shares is at $869.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>ACM Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) shares declined by 12.84% to $18.13. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) shares declined by 11.88% to $6.83. The market value of their outstanding shares is at $434.8 million. </li>
<li>Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) stock decreased by 11.63% to $9.12. The market value of their outstanding shares is at $3.1 billion. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACMR

FCUV

LCFY

NVNI

PONY

SAIH

SGMA

UCTT

WOLF

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Historically, markets deliver weaker and more volatile returns during the May through October timeframe than any other time of the year. Hence, the old adage: "Sell in May and go away." Negative May through October returns, though, typically show up<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/45069781/trumps-first-100-days-what-he-delivered-where-he-fell-short-how-markets-reacted"> only in bear markets.&nbsp;</a>
What To Know: Callum Thomas, head of research for Top Down Charts, claims that the old adage "Sell in May and go away" oversimplifies reality. While the May-October stretch often underperforms, seasonality behaves differently in bull versus bear markets.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/legal/25/04/45056354/alexandria-ocasio-cortez-askshow-much-did-majorie-taylor-greene-make-when-she-bought-the-dip?utm_source=articleShare">Alexandria Ocasio-Cortez Asks,&#8217;How Much Did Majorie Taylor Greene Make When She Bought The Dip?&#8217;</a>
Thomas says the "Sell in May" effect is most pronounced during bear markets, but bull markets still see gains, just with more bumps.
In bull markets, May through October still produces positive returns less often than November through April. In bear markets, the odds of losses spike during the May through October window.
This year, the S&amp;P 500, as tracked by the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), is down 5.61% heading into May. 
Why Does This Happen: Economic data and investor sentiment tend to be weaker from May to October, which Thomas says may help explain the seasonal dip.&nbsp;
The U.S. dollar often weakens, while oil prices tend to rise during this period. Defensive assets, like treasuries and gold, often outperform during the May through October stretch, reflecting the risk-off mood.
What Else: Averages can be misleading, Thomas warns, and the performance gap between the two periods has been shrinking in recent years. Seasonality should be considered as part of a strategy, but not as a stand-alone investment thesis.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/45012792/trump-administration-to-resume-collections-on-student-loans-5-million-borrowers-in-default?utm_source=articleShare">Trump Administration To Resume Collections On Student Loans: 5 Million Borrowers In Default&nbsp;</a></li>
</ul>
Photo: Shutterstock

Social Media

Broad U.S. Equity ETFs

ETFs

'Sell In May And Go Away?' Only In Bear Markets, One Expert Says

KEYS

Keysight Technologies Collaborates With Intel Foundry To Support Embedded Multi-Die Interconnect Bridge-T Technology

Gibraltar Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROCK#NASDAQ">ROCK</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.
Analysts estimate that Gibraltar Industries will report an earnings per share (EPS) of $0.81. 
Investors in Gibraltar Industries are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.10, leading to a 0.74% increase in the share price the following trading session.
Here's a look at Gibraltar Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.91</td>
<td>1.25</td>
<td>1.25</td>
<td>0.72</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.01</td>
<td>1.27</td>
<td>1.18</td>
<td>0.80</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>0.0%</td>
<td>0.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745946221_0.png" alt="eps graph" />
<h3>Tracking Gibraltar Industries's Stock Performance</h3>
Shares of Gibraltar Industries were trading at $52.59 as of April 28. Over the last 52-week period, shares are up 486.51%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/ROCK/earnings">To track all earnings releases for Gibraltar Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ROCK

Earnings Preview: Gibraltar Industries

Climb Global Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) will release its quarterly earnings report on Wednesday, 2025-04-30. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Climb Global Solutions to report an earnings per share (EPS) of $0.89.
The market awaits Climb Global Solutions's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
The company's EPS beat by $1.14 in the last quarter, leading to a 12.78% increase in the share price on the following day.
Here's a look at Climb Global Solutions's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.12</td>
<td>0.85</td>
<td>0.48</td>
<td>0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.26</td>
<td>1.55</td>
<td>0.83</td>
<td>0.60</td>
</tr>
<tr>
<td>Price Change %</td>
<td>13.0%</td>
<td>-3.0%</td>
<td>13.0%</td>
<td>-11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745946206_0.png" alt="eps graph" />
<h3>Tracking Climb Global Solutions's Stock Performance</h3>
Shares of Climb Global Solutions were trading at $107.28 as of April 28. Over the last 52-week period, shares are up 61.86%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Climb Global Solutions</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Climb Global Solutions.
Analysts have given Climb Global Solutions a total of 2 ratings, with the consensus rating being Outperform. The average one-year price target is $136.0, indicating a potential 26.77% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Ingram Micro Holding, Insight Enterprises and Avnet, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Ingram Micro Holding, with an average 1-year price target of $25.8, suggesting a potential 75.95% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Insight Enterprises, with an average 1-year price target of $160.0, suggesting a potential 49.14% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Avnet, with an average 1-year price target of $50.0, suggesting a potential 53.39% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
In the peer analysis summary, key metrics for Ingram Micro Holding, Insight Enterprises and Avnet are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Climb Global Solutions</td>
<td>Outperform</td>
<td>51.48%</td>
<td>$31.25M</td>
<td>7.65%</td>
</tr>
<tr>
<td>Ingram Micro Holding</td>
<td>Buy</td>
<td>2.50%</td>
<td>$936.09M</td>
<td>2.26%</td>
</tr>
<tr>
<td>Insight Enterprises</td>
<td>Neutral</td>
<td>-7.31%</td>
<td>$439.64M</td>
<td>2.09%</td>
</tr>
<tr>
<td>Avnet</td>
<td>Neutral</td>
<td>-8.73%</td>
<td>$596.05M</td>
<td>1.77%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Climb Global Solutions ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the lowest Return on Equity. Overall, Climb Global Solutions stands out for its strong revenue growth and gross profit performance compared to its peers, despite a lower return on equity.
<h3>Unveiling the Story Behind Climb Global Solutions</h3>
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
<h3>Breaking Down Climb Global Solutions's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining Climb Global Solutions's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 51.48% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Climb Global Solutions's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.21% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Climb Global Solutions's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 7.65%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.62%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.03, Climb Global Solutions adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/CLMB/earnings">To track all earnings releases for Climb Global Solutions visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLMB

Insights into Climb Global Solutions's Upcoming Earnings

PC Connection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXN#NASDAQ">CNXN</a>) will release its quarterly earnings report on Wednesday, 2025-04-30. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate PC Connection to report an earnings per share (EPS) of $0.41.
The market awaits PC Connection's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.12, leading to a 10.81% drop in the share price on the subsequent day.
Here's a look at PC Connection's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.90</td>
<td>1</td>
<td>0.83</td>
<td>0.63</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>0.97</td>
<td>1</td>
<td>0.50</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-11.0%</td>
<td>-5.0%</td>
<td>5.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745946198_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of PC Connection were trading at $61.97 as of April 28. Over the last 52-week period, shares are up 0.24%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/CNXN/earnings">To track all earnings releases for PC Connection visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNXN

A Preview Of PC Connection's Earnings

MYR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.
Analysts estimate that MYR Group will report an earnings per share (EPS) of $1.17. 
MYR Group bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.31, leading to a 4.67% drop in the share price on the subsequent day.
Here's a look at MYR Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.68</td>
<td>0.35</td>
<td>1.13</td>
<td>1.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.99</td>
<td>0.65</td>
<td>-0.91</td>
<td>1.12</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>14.000000000000002%</td>
<td>-22.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745946191_0.png" alt="eps graph" />
<h3>Performance of MYR Group Shares</h3>
Shares of MYR Group were trading at $122.95 as of April 28. Over the last 52-week period, shares are down 25.22%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/MYRG/earnings">To track all earnings releases for MYR Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MYRG

Uncovering Potential: MYR Group's Earnings Preview

U.S. Secretary of Commerce Howard Lutnick has outlined a bold vision to position the United States as the global leader in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) innovation, <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45017261/bitcoin-mining-costs-jump-to-137000-per-coin-when-accounting-for-non-cash-expenses-coinshares">starting with mining</a>.
What Happened: In a Bitcoin Magazine exclusive interview on April 28, Lutnick <a href="https://www.youtube.com/watch?v=BPlnUxDblaE">proposed</a> a revolutionary approach: allowing Bitcoin miners to build power plants directly at mining sites, including the ability to place data centers &#8220;on top of gas fields&#8221; with dedicated energy sources.
This would eliminate reliance on the broader electrical grid and enable miners to scale sustainably.
&#8220;If you want to mine Bitcoin and find the right place to do it, you can build your own power plant next to it,&#8221; Lutnick said.
This strategy falls under the Investment Accelerator program, which offers regulatory support for large-scale investments in U.S. infrastructure: investments over $1 billion get streamlined permitting assistance. 
Projects over $10 billion receive dedicated full-time government liaisons offering &#8220;white glove service.&#8221;
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45048427/watch-this-bitcoin-indicator-to-know-if-a-run-to-100000-is-coming">Watch This Bitcoin Indicator To Know If A Run To $100,000 Is Coming</a>
Why It Matters: Lutnick, who began investing in Bitcoin in 2017 and went &#8220;all in&#8221; by 2020, emphasized that this administration is crypto-forward. 
There are three major Bitcoin advocates in key positions: President Trump, &#8216;Crypto Czar&#8217; David Sacks, and myself, he said.
He likened Bitcoin to gold, arguing it should be treated as a commodity, not a security: "What is Bitcoin like? It's like gold… You should be able to buy and sell Bitcoin freely—it's a commodity." 
Lutnick also revealed discussions within the Bureau of Economic Analysis to treat Bitcoin similarly to gold bullion in national economic data, a move that could elevate its standing in financial reporting.
What's Next: While Lutnick declined to update the status of a proposed Bitcoin strategic reserve audit, he reaffirmed that the administration has delivered on key promises to the crypto industry.
He noted that further Bitcoin-focused policies will resume after the administration addresses global trade and geopolitical stability.
Lutnick contrasted the current approach with the prior administration, saying: "was treated under the Biden administration like you were doing something wrong&#8230;now you have that sort of in the rearview mirror and then it&#8217;s gone and it&#8217;ll never come back.&#8221;
Read Next:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/45036669/bitcoin-supply-squeeze-will-drive-run-to-new-highs-bernstein">Bitcoin Supply Squeeze Will Drive Run To New Highs: Bernstein</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Is A Commodity Like Gold, Says Commerce Secretary Lutnick

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) is preparing to release its quarterly earnings on Wednesday, 2025-04-30. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Cimpress to report an earnings per share (EPS) of $0.55.
Investors in Cimpress are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.07, leading to a 5.48% drop in the share price the following trading session.
Here's a look at Cimpress's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.43</td>
<td>0.29</td>
<td>0.95</td>
<td>0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.36</td>
<td>-0.50</td>
<td>4.33</td>
<td>-0.15</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>-9.0%</td>
<td>5.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745946183_0.png" alt="eps graph" />
<h3>Market Performance of Cimpress's Stock</h3>
Shares of Cimpress were trading at $41.97 as of April 28. Over the last 52-week period, shares are down 49.62%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/CMPR/earnings">To track all earnings releases for Cimpress visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CMPR

What to Expect from Cimpress's Earnings

Press Releases

Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company's Mission

Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly's Leading AI Biotechs

Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump's Initiative to Encourage Pharmaceutical Manufacturing in United States

Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ's Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald

Contracts

Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction

Small Cap

WHO and WEF Are Pushing AI in Global Healthcare -- What It Means for the Market

Tevogen Bio Finalizes Agreement for Company's Own Cell Therapy Production Facility

Tevogen Bio Announces 2025 Annual Meeting

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion

AMST

AVAI

BTAI

PLTR

TVGN

TVGNW

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

Fate Therapeutics

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Genfit

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Inhibrx Biosciences

INmune Bio

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Korro Bio

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nanobiotix

Nkarta

Puma Biotechnology

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tango Therapeutics

Y-mAbs Therapeutics

D. Boral Capital

Tevogen Bio Holdings shares are trading higher after the company reaffirmed its oncology pipeline revenue forecast, projecting $1 billion in its launch year and a cumulative five-year estimate of $10 billion to $14 billion.

Comments

Tevogen Bio Holdings

空売り

Tevogen Bio Holdings (NASDAQ:TVGN) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル